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Abstract
Characterizing the stability of the gut microbiome is important to exploit it as a therapeutic target 
and diagnostic biomarker. We metagenomically and metatranscriptomically sequenced the faecal 
microbiomes of 308 participants in the Health Professionals Follow-Up Study. Participants 
provided four stool samples—one pair collected 24–72 h apart and a second pair ~6 months later. 
Within-person taxonomic and functional variation was consistently lower than between-person 
variation over time. In contrast, metatranscriptomic profiles were comparably variable within and 
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between subjects due to higher within-subject longitudinal variation. Metagenomic instability 
accounted for ~74% of corresponding metatranscriptomic instability. The rest was probably 
attributable to sources such as regulation. Among the pathways that were differentially regulated, 
most were consistently over- or under-transcribed at each time point. Together, these results 
suggest that a single measurement of the faecal microbiome can provide long-term information 
regarding organismal composition and functional potential, but repeated or short-term measures 
may be necessary for dynamic features identified by metatranscriptomics.
Understanding the temporal dynamics of the healthy adult gut microbiome is integral in 
leveraging these microbial communities to promote human health. Large-scale changes in 
microbial composition have been associated with host health overall1–3, but inferring 
causality and developing personalized therapies will require large-scale prospective cohort 
studies. Furthermore, to exploit the faecal microbiome as a predictive biomarker or 
eventually as a diagnostic tool in clinical settings, it is critical to be able to discriminate 
between normal versus pathological variation over time4.
Previous efforts have provided excellent characterization of the ecological stability of the 
adult faecal microbiome4–13. All measures of stability in microbial communities must be in 
the context of relative differences since, despite daily variability in species’ relative 
abundances, microbial communities in the gut microbiome have been observed to be 
generally consistent over time, even on the scale of years or decades4,5,14,15. This relative 
stability appears to be due to individually persistent strains within individual hosts5,16. 
Moreover, specific inter-individual differences in community structures appear to be 
preserved over the long-term17, allowing an individual’s faecal microbiome to be uniquely 
distinguished from that of others to serve as a faecal microbial fingerprint13. Nonetheless, 
despite the relative stability of the community profile over the long-term, recent studies have 
shown that host lifestyle or exposures such as a sudden change in diet, the initiation of 
antibiotics or the acquisition of pathogenic species can lead to profound disruptions in the 
microbiome9,18,19. When such pressures are lifted, the host’s faecal microbiome generally 
recovers to a composition comparable to its original state9.
An understanding of microbiome stability as it affects taxonomic and functional features is 
vital for applying it diagnostically or prognostically in long-term public health studies. 
Different molecular features, including strain membership, species abundances, functional 
profiles or metatranscription, may all prove to be informative regarding host health 
conditions and they are likely to differ dramatically in their relative stability within and 
between subjects over time20. The Human Microbiome Project (HMP), for example, found 
that in the absence of perturbations from disease or overt xenobiotics, metagenomic 
functional profiles were more comparable between individuals, while strains were stable 
within subjects17. Even fewer studies have focused on the metatranscriptome, an indicator of 
different aspects of microbial functional activity21,22. Finally, the dynamics of response in 
any of these features to known dietary and xenobiotic perturbations are themselves not yet 
fully known23,24. Thus, the magnitude of changes in microbial composition, functional 
potential and gene expression that occur over various time intervals and their utility for 
molecular epidemiology are unclear.
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To address these knowledge gaps, we deeply characterized the faecal microbiome among 
308 individuals enroled in the Men’s Lifestyle Validation Study (MLVS), nested within the 
ongoing population-based Health Professionals Follow-up Study (HPFS)—a prospective 
cohort of 51,529 men followed since 1986. This cohort provided an unparalleled opportunity 
to apply insights from community ecology and epidemiology to characterize the stability of 
the faecal microbiome structure and function over time. Specifically, we hypothesized that 
inter-individual differences in faecal microbiome communities and metagenomes would 
persist over short- (24–72 h) and intermediate-term (6 months) intervals, but that 
metatranscriptomes would demonstrate greater variability over time. The work described 
here characterizing faecal microbial stability is accompanied by further research on 
molecular function in the faecal metagenome and metatranscriptome population25. These 
studies will provide a foundation for leveraging the faecal microbiome as a biomarker for 
population-based cohort studies and provide insight into how metagenomics and 
metatranscriptomics relate to each other over time.
Results
The faecal metagenome is more stable than the metatranscriptome
We first quantified the longitudinal stability of metagenomic taxonomic profiles, functional 
profiles and metatranscriptomes in MLVS subjects. Our approach is detailed in Fig. 1. 
Participants provided up to four stool samples—a set of stool samples collected 24–72 h 
apart followed by collection of a second set approximately 6 months later. DNA was 
extracted from 929 samples collected from all 308 men. RNA was extracted and reverse-
transcribed to complementary DNA from 378 samples from participants who provided a 
stool at both sampling time points and who did not report the use of antibiotics within the 
past year. All samples were then sequenced using the Illumina HiSeq platform (see 
Methods). Raw sequence data were filtered to remove low-quality and human host reads and 
features with low overall relative abundance. Metagenomic and metatranscriptomic reads 
were profiled for functional and taxonomic composition using HUMAnN2 (ref. 26) and 
MetaPhlAn2 (ref. 27), respectively.
We compared the within-person stability of the faecal metatranscriptome (functional 
elements from RNA) with the stability of taxonomic composition (species from DNA) and 
the metagenome (functional elements from DNA) over short (24–72 h) and intermediate (6 
month) time intervals. This was assessed by calculating two β-diversity metrics—the Jaccard 
index (for membership) and Bray–Curtis (BC) dissimilarity (for abundance)—between an 
individual’s samples collected over the study period. In accordance with our earlier pilot 
study21, the metagenomic functional potential (DNA) was more stable than the 
metatranscriptome (RNA), which was in turn more stable than taxonomic profile abundances 
(species) (Fig. 2a).
In addition, we tested whether the stability of microbiome features was consistent over 
short- and intermediate-term intervals. Species, DNA and RNA features that remained stable 
within a subject over a 24–72 h period tended to be similarly stable over 6 months 
(Spearman’s r =0.99, two-tailed P <2.2×10−16), suggesting the presence of a subset of 
features that can be consistently measured over time.
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Between-person exceeds within-person metagenomic variation
As in previous studies of the faecal microbiome17, individuals’ microbial community 
structure and metagenomic functional potential were more self-similar (red boxes) over time 
than between subjects (blue boxes) (Fig. 2b). This remained consistent over short- (24–72 h) 
and intermediate-term (6 month) periods (within-person variation versus between-person 
variation for all four Mann–Whitney U tests: P <2.2×10−16). In contrast, we found that 
within- and between-subject variation over short- and intermediate-term periods was 
comparable for metatranscriptomes (short term Mann–Whitney U test: P = 0.25; 
intermediate term Mann–Whitney U test: P =0.50).
To additionally quantify the proportion of variation that can be attributed to between-subject 
variation for the purposes of prospective population-based cohort studies, we estimated 
intra-class correlation coefficients (ICCs). The majority of species and genes (86.8 and 
92.8%, respectively) retained ICCs greater than 0.40 over the longest sampling interval in 
our study. In contrast, only a small fraction of transcripts (0.79%) had an ICC greater than 
0.40 (Supplementary Table 1).
Taken together, these data suggest that specific inter-individual differences in faecal 
microbiome organismal composition and functional potential appear to be preserved over 
intervals up to at least six months and thus may be more reliably associated with long-term 
health outcomes using a limited number of measurements. In contrast, the more dynamic 
features of the metatranscriptome may be more informative regarding short-term events.
Feature abundance and prevalence are associated with stability
Feature consistency over short- and intermediate-term periods led us to consider if there may 
be properties inherent to features that contribute to stability across all hosts. Across a range 
of body sites, overall taxonomic stability of the human microbiome is correlated with feature 
abundance and prevalence13. We extended these results by exploring the correlations 
between these two ecological properties and the stability of individual organisms in the 
faecal microbiome, as well as the stability of the genomic and transcriptomic levels of 
individual enzymes. As in previous analyses where dissimilarity metrics have been used for 
individual features5, using the complement of within-person BC dissimilarity score (1 – BC) 
over the longest interval in our study (time point 1 versus time point 4; ~6 months), we 
similarly found that baseline feature prevalence and abundance were also strongly and 
positively correlated with not only organismal composition, but also genomic and 
transcriptional stability (Fig. 3). Many species that were highly abundant and prevalent in 
this population were highly stable, including the well-characterized Bacteroides uniformis 
(dark green circle) and Faecalibacterium prausnitzii (orange circle)28. In contrast, species 
that were of low prevalence and abundance were less stable, including those that were 
probably carried from the oral cavity including Lactococcus lactis (black circle) and 
Streptococcus thermophilus (dark purple circle)21,29. Similarly, enzymes such as RNA 
polymerase (red circle) (EC (Enzyme Commission) 2.7.7.6), which are essential for 
prokaryotic function, were universally prevalent, highly abundant and stably expressed at the 
genomic and transcriptional level.
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Notably, however, there were select features for which the stability levels did not correspond 
with their prevalence or abundance. For example, Sutterella wadsworthensis (blue circle), 
was in the bottom quintile for prevalence and the bottom half for abundance, but it was in 
the top quintile for stability. This may be due to the role of this species’ lone production of 
the adenosine 3′-phosphate-5′-phosphosulfate-independent sulfuryl transferase (EC 
2.8.2.22)—an important microbial enzyme involved in the detoxification of phenolic 
compounds30,31. Similarly, Bacteroides plebius (light purple circle), found to occupy a 
unique role in starch utilization, was found in the bottom quintile for prevalence but in the 
top quintile for stability32. Additionally, as observed in the HMP, there were genes that were 
universally prevalent at the DNA level but of relatively low genomic abundance17. Many of 
these enzymes had some of the most variable gene expression. For example, the pair of 
enzymes thiaminase I and II (EC 2.5.1.2 and EC 3.5.99.2), which are involved in the 
microbial degradation of thiamin, possessed DNA sequences detected in 100% of 
participants, but were within the bottom 5% of stable transcripts33. Similarly, the enzyme 
ErmC (EC 2.1.1.184), which encodes one of the macrolide resistance genes was universally 
prevalent at the genomic level but was unstable at the RNA level and of intermediate 
stability at the genomic level34.
Host factors that may influence faecal microbiome stability
In addition to examining determinants of stability for specific features, we assessed whether 
there were lifestyle factors or behaviours at the time of stool collection that could explain 
global instability of the faecal microbiome for each individual. There have been inconsistent 
data on the effects of antibiotics and bowel preparation on the faecal microbiome 
composition and limited data on temporal change in the metagenome19,24,35–38. In addition, 
ecological theory suggests that species-rich communities may have a greater compensatory 
capacity for disturbances in the ecosystem39,40.
In an exploratory analysis, we examined the association of putative host or environmental 
factors that may influence the stability of microbial community structure or pathways over a 
longer period. To do this, we calculated BC dissimilarity values for each individual over the 
longest sampling interval (around six months) using species, genes and transcripts as our 
response variables. As shown in Table 1, there were few factors that consistently explained 
instability. However, common predictive factors across feature types included mean Shannon 
index values (α-diversity) and exposure to a bowel laxative preparation within the two 
months before collection. Antibiotic use during the six-month period between sample 
collection seemed to affect genomic instability to a slightly greater extent than species 
instability. However, the overall low correspondence between antibiotic usage and 
dissimilarity suggests that faecal ecological variability may either be attributed to additional 
exogenous factors not measured here or to endogenous and perhaps stochastic host–
microbial interactions.
Relating metagenomic and metatranscriptomic stability over time
Next, we considered the degree to which transcriptomic stability is related to metagenomic 
stability, since the central dogma suggests that DNA copy number changes are likely to 
influence transcript levels. Recent evidence from a pilot study involving a subset of these 
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participants (n = 8) found that many gene and transcript relative abundances were well 
correlated and that a substantial fraction (41%) of microbial transcripts were basally 
regulated21. Again using the complement of the within-person BC dissimilarity score over 
six months as our metric of stability, we found that genomic instability appears to explain a 
large proportion of transcriptomic instability (Spearman’s r = 0.86; r2 = 0.74 = 74%; P 
<2.2×10−16). To further investigate whether this trend is driven by a small number of highly 
expressed genes, we divided our dataset into genes that were prevalently expressed (defined 
as transcripts detected in >90% of samples; n = 1,049) and genes that were variably detected 
(n =754). When comparing r2 values for these two groups, we did not observe an 
appreciable difference (0.56 versus 0.48). However, we found that among only the 
transcripts in the bottom 10% of prevalence (n = 176), a similar strength in association was 
not seen (r2 =0.01), suggesting that measured expression of these genes is influenced by 
other factors.
In addition, we investigated whether dominant expression of stable versus unstable genes 
varied according to species. For each transcript, a dominant contributing species was 
identified based on the maximal average contributing organism for each transcript from 
HUMAnN2 (see Methods). We then ranked species according to the total number of genes 
that they dominantly expressed (Fig. 4). As shown, Bacteroides species are dominant 
contributors to the greatest number of genes expressed, as well as dominant contributors to 
the expression of the most stable transcripts. In contrast, Streptococcus species are dominant 
contributors to the expression of some of the most unstable transcripts. Interestingly, these 
are not typically viable gut residents21, suggesting that some species play more variable 
roles because they are rare, transitory, more prone to influence by environmental factors or 
possibly under-sampled.
Stability of gene expression over time
The previous section highlighted that much of the transcriptional variability over time for 
each feature was associated with changes in the metagenome. Thus, next we queried what 
proportion of the remainder of transcriptional variation could be explained by differences in 
the transcriptional expression of features over time. In an approach similar to that performed 
in the pilot study21, we identified significantly differentially transcribed pathways, defined 
as having a mean log RNA/DNA abundance ratio >2 for all four time points and then 
explored where they overlapped. Of the 218 pathways that were significantly differentially 
expressed, 79% were consistently over- or under-expressed across three or four time points 
(Fig. 5a).
To better understand which pathways were most stably expressed, for each time point, we 
computed the mean RNA/DNA ratio (see 'RNA/DNA normalization' in the Methods of the 
accompanying manuscript by48 for each pathway across the 85 participants who gave 4 
samples for transcriptomic analysis. We then calculated the coefficient of variation for these 
means and ranked the pathways by their coefficient of variation (Fig. 5b). The top eight 
resulting most stable pathways in terms of transcriptional regulation appear to be involved in 
cellular housekeeping, such as carbon metabolism (stably over-expressed) and amino acid 
synthesis (stably under-expressed).
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Discussion
Here, we quantify faecal microbiome stability for prospective population-based cohort 
studies, with a particular focus on the relationship between metatranscriptomic features and 
the metagenome (both organismal composition and functional potential). See also ref. 48 for 
a discussion of the molecular and functional activity. As expected from single organisms and 
human studies, metatranscriptomic variation exceeded that of the metagenome. In addition, 
unlike the metagenome, metatranscriptomic variation within individuals over time was 
higher, to the point that it was comparable to variation between individuals. Taken in 
combination with our accompanying report describing a relatively stable 'core' 
metatranscriptome48, these findings, combined with previous reports21,23,24, suggest a 
model in which gut microbial community function mirrors that of differentiated human cell 
types: a subset of transcripts are prevalently active in the gut from varied microbes and 
conditions, while the remainder respond dynamically to intrinsic or external factors, such as 
diet.
In addition, we found the striking result that approximately 74% of the instability in the 
faecal metatranscriptome can be explained by instability in the faecal metagenome. These 
findings are similar to those from our pilot study, which showed that at a single time point, 
more than half of the variation in microbial community gene expression can be explained by 
metagenomic composition. This is best illustrated by our finding that some of the most 
highly stable (as well as highly abundant and prevalent) species, such as B. uniformis, were 
responsible for the dominant expression of a large number of stable genes. In contrast, 
Streptococcus salivarius—an unstable species that is probably transiting from the oral 
microbiome21—dominantly expresses many of the most variable genes. Similar findings 
were found in relation to the regulation of gene expression. Of the genes we identified as 
significantly differentially transcribed, nearly 80% were consistently over- or under-
expressed. Many of these stably expressed pathways appeared to be essential for cellular 
function or involved in glycolysis, the synthesis of amino acids or the production of short-
chain fatty acids. Taken together, it appears that much of the metatranscriptomic variation in 
stools over time might reflect changes in gene family copy number, driven by factors such as 
the proliferation of microbes, introduction of new species or host-induced shifts in 
community structures. In contrast, in the face of relative metagenomic stability, substantial 
deviations from a common genomic profile may be associated with shifts in disease 
state41,42.
Of course, we observed exceptions to these patterns, which may additionally explain some 
of the instability in the function of the faecal microbiome. Some species, such as S. 
wadsworthensis and Methanobrevibacter smithii, despite their stable presence, appear to be 
dominant contributors to the expression of unstable genes. Especially in the case of 
functionally unique taxa such as the archaea, this suggests specialized roles associated with 
targeted, highly variable activity over time. In addition, we found gene families with levels 
of RNA stability that were discordant with DNA stability, as well as several pathways that 
were differentially transcribed (up or down) only at a single time point. Given the large 
relative time scales of even our shortest gap (1–3 days) compared with transcriptional 
regulation (minutes), these changes are difficult to interpret without further data, but they 
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may indicate pathways particularly susceptible to modulation by xenobiotics, diet or other 
targeted perturbations23,24. These outlying genes with high metagenomic stability but 
variable metatranscriptomic levels, or the stable microbes leading to the expression of 
unstable genes, are likely to play a critical role in our understanding of the impact of host 
behaviour on the faecal microbiome48.
Finally, for the purposes of prospective, longitudinally followed cohort studies, our study is 
consistent with previous work and indicates that many long-term features of the faecal 
microbiome are well-represented in a single self-collected stool sample4,5,17,21. These 
include strain composition, general taxonomic abundances and core metagenomic functional 
profiles. Furthermore, our results suggest that, as expected, metatranscriptomes vary over 
time and are appropriate markers for short-term exposures, and not necessarily long-term 
exposure–disease relationships. They do, however, remain somewhat personalized, and 
subsets of microbial transcripts are individually more stable. It remains to be determined 
which of these microbiome features, if any, represent the best biomarkers for diagnosis or 
prognosis of health conditions in diverse human populations.
Moving forward, the large-scale, population-based collection of stools is critical to exploring 
the factors that promote a stable core functional microbiome, yet yield unique species and 
metagenomic profiles. Prospective cohort studies characterizing the microbiome in relation 
to lifestyle data, such as dietary and medication information, have already begun to explore 
inter-individual variation and will be essential in mechanistically understanding the 
interactions between the faecal microbiome and the host in the context of health and 
disease17,43–45. Continuing to improve our understanding of the stability of the faecal 
microbiome function is critical not only in determining the ecological dynamics of the 
human microbiome25, but also for the promotion of human health.
Methods
Study population
The HPFS is an ongoing prospective cohort study that began in 1986 among 51,529 US 
male podiatrists, dentists, osteopathic physicians, veterinarians, pharmacists and 
optometrists aged 40 to 75 years at enrolment. In this study, participants returned 
questionnaires every 2–4 years with greater than 90% follow-up to provide information 
about lifestyle and dietary factors, medication use, and diagnoses of colorectal cancer and 
other diseases. The MLVS was established among 700 men aged 52–81 years (median 69 
years) nested within HPFS who had completed the 2010 food frequency questionnaire and 
previously provided a blood sample. Men with coronary artery disease, stroke or transient 
ischaemic attack, cancer (except squamous or basal cell skin cancer) or major neurological 
disease (amyotrophic lateral sclerosis, Alzheimer’s, Parkinson’s, epilepsy or multiple 
sclerosis) were excluded. The 308 individuals sampled in this study were recruited into the 
MLVS starting in July 2012 and ending in July 2013. Participant recruitment and protocols 
were approved by the Harvard T. H. Chan School of Public Health Institutional Review 
Board #HSPH 22067-102. All participants provided informed consent for the study.
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Sample size rationale
A tiered study design with metagenomic sequencing and a smaller batch of 
metatranscriptomic sequencing was used to determine both the composition and metabolic 
potential of the faecal microbiota. From the HMP findings of ~300 taxa per sample, our 
sample was estimated to yield relative abundances with standard deviation quartiles of 
(0.016, 0.027, 0.058) among rare taxa (present in < 50% of samples) and (0.081, 0.10, 0.15) 
among common taxa (arcsine square root-transformed relative abundance units).
Sample collection
Participants provided up to four stool samples—a set of samples from two consecutive 
bowel movements 24–72 h apart followed by collection of a second set of two such samples 
approximately 6 months later. Our collection protocol had previously been validated (see 
Supplementary Discussion)21. Briefly, participants deposited each bowel movement into a 
plastic commode collection bowl and then, using a specially designed spoon attached to a 
collection tube cap, faeces were scooped into a tube containing RNAlater. At each stool 
collection, participants documented the date and time of defecation as well as the Bristol 
score46. In addition, concurrent with each set of samples, participants completed a brief 
questionnaire collecting information regarding their recent use of antibiotics, gastric-acid-
reducing medications, laxatives and probiotics, as well as other relevant exposures. At each 
time point, participants stored the specimen in the RNAlater fixative at ambient temperature 
until the specimen collected from the second bowel movement was produced. Each set of 
stool specimens was then placed in a special mailing kit and returned at ambient temperature 
by overnight mail. Upon receipt, the collection tubes were immediately placed into −80 °C 
freezers.
Sample handling and nucleic acid extraction
DNA and RNA extraction, processing and sequencing were as published21. Briefly, 100 mg 
stool aliquots were centrifuged at maximum speed to remove the excess of RNAlater. To the 
pellet, 110 μl of Tris-EDTA buffer with Proteinase K (Qiagen) and lysozyme (Sigma–
Aldrich) (15 mg ml−1) were added with incubation on a laboratory shaker for 10 min. The 
mechanical lysis was performed by the addition of a 1.2 ml RLT buffer with 2-
mercaptoethanol (Qiagen) and 1 ml of 0.1 mm glass beads (BioSpec Products), followed by 
bead beating for 3 min. The debris were removed by centrifugation and the supernatant was 
used in Qiagen AllPrep spin columns according to the manufacturer’s protocol (Qiagen). 
The only exception was in the preparation of the RNA: 60 μl DNase solution was added to 
buffer RW1 and incubated at room temperature for 15 min, followed by another wash with 
RW1 buffer. A NanoDrop 1000 (Thermo Fisher Scientific) was used to determine the DNA 
and RNA concentrations, quality and purity. SUPErase In was added to the aliquot before 
freezing. RNA was extracted and reverse-transcribed to complementary DNA only from 
stool samples spanning 6 months from participants who did not report the use of antibiotics 
within the past year (Fig. 1). RNA sequencing (RNA-Seq) libraries were depleted for 
ribosomal RNA using Ribo-Zero (Epicentre) as previously described21.
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DNA was extracted from all 929 samples. RNA was extracted from 378 samples derived 
from a subset of 96 individuals who provided all four stool samples spanning the 6-month 
study interval and who did not report the use of antibiotics within the past year.
Library prep, sequencing and taxonomic/functional profiling
We used the Nextera XT DNA Library Preparation Kit for whole-genome sequencing. For 
RNA-Seq, we used RNAtag-Seq—a method to create an RNA-Seq library containing large 
numbers of RNA samples that are bar-coded and pooled before library construction47. This 
approach does not require poly(A) capture/enrichment or random priming.
Using Illumina HiSeq paired-end (2 × 101 nucleotides) shotgun sequencing, 929 
metagenomes and 378 metatranscriptomes were obtained. Six RNA samples were not 
sequenced due to platform constraints. After sequencing and before biocomputing quality 
control, the sequencing depth (mean ±s.d.) for DNA was 3.8 ± 1.6 giganucleotides (Gnt). 
After quality control, it was 1.8 ± 0.7 Gnt. For RNA, the mean sequencing depth was 2.8 
± 2.4 Gnt before quality control and 1.2 ± 1.0 Gnt after. The quality control step included 
the removal of human sequences, quality trimming and depletion of duplicate reads using 
HMP protocols (HMP) with KneadData (http://huttenhower.sph.harvard.edu/kneaddata).
We then performed taxonomic profiling with MetaPhlAn2 (ref. 27) and functional profiling 
of genes and transcripts using HUMAnN2 (ref. 26). Outlier identification was performed and 
eight samples were removed because their ordination scores in either dimension (NMDS1 or 
NMDS2) were outside the range of the median ± 3 interquartile ranges. Notably, four of 
these samples were provided by a participant who reported a history of colectomy 
(Supplementary Fig. 1). Six RNA samples were removed because they did not have 
matching DNA-sequenced samples. We subsequently filtered all taxonomic features with a 
relative abundance less than 10−4 (0.01%) in greater than 10% of all samples. Similarly, for 
DNA and RNA, we filtered all gene families with a relative abundance less than 10−5 
(0.001%) in greater than 10% of all samples.
Statistical analysis
Variability in the relative abundance values for community composition, metagenomes and 
metatranscriptomes within and between samples was determined by calculating the BC 
dissimilarity metric for each individual over time17. Short-term intervals, as previously 
described, were defined as consecutive bowel movements (24–72 h apart), whereas the 
intermediate interval was six months—the longest sampling interval in the study. Similarly, 
the Jaccard index was calculated within samples across time, where comparisons were 
drawn between the first sample and the remaining three5. With these metrics, higher values 
signify more variable features, whereas lower values indicate more stable features.
To estimate the reliability or reproducibility in measuring relative abundance values of 
features over time, we calculated ICCs. Relative abundance values were first arcsine square 
root-transformed to variance-stabilize data and better approximate normality and then, using 
linear mixed-effects models with restricted maximum likelihood estimation, we divided the 
between-person variance by the sum of the within- and between-person variances48. In a 
previous study, in simulations on proportion data, this approach performed similarly to 
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generalized linear mixed model-based estimates of ICCs using multiplicative models fitted 
by penalized quasi-likelihood estimation and from additive models fitted by Markov chain 
Monte Carlo sampling48.
We explored whether several putative factors (bowel preparation use, antibiotic use, acid-
lowering medication, and so on) were associated with within-person community, 
metagenome and metatranscriptome stability across the longest interval in our study using 
linear models. The Shannon index was calculated to be the mean of the within-sample 
diversity at time point 1 and time point 4. Acid-lowering medication use was determined by 
the use of proton-pump inhibitors or H2 receptor antagonists more than once a week for two 
months. Bowel preparation was determined as any use of bowel preparation in the two 
months before stool collection. Antibiotic use was defined as the oral or intravenous 
administration of antibiotics in the 12 months before stool collection. Those who never used 
antibiotics were set as the reference level. 'Any antibiotics' users were defined as participants 
using antibiotics at any point during the 12 months before the second stool collection and 
'new antibiotics' users were defined as non-users of antibiotics before collection time point 1 
who had initiated the use of antibiotics after the first collection and before the second. The 
Bristol category change was determined by categorization of participant-reported Bristol 
stool scores into hard (1–2), normal (3–4) and soft or liquid (5–7) categories and then 
calculating the difference between the categories over time46.
We examined associations between the baseline mean relative abundance and prevalence of 
each feature versus feature stability, and how metagenomic variability correlated with 
metatranscriptomic variability for each feature over time. As part of this, we investigated 
whether dominant expression of stable genes versus the expression of unstable genes varied 
according to species. For each transcript, a dominant contributing species was identified 
based on the maximal average contribution to each transcript. We then ranked the species 
according to the total number of genes that they dominantly expressed and (for presentation 
purposes) selected those contributing to 30 or more and overlaid them on a scatterplot in 
colour (grouped by genus). Examples of this process are presented in Figs. 3 and 4.
To test the stability of gene expression over time, we identified 740 pathways found in the 
340 samples for which we had DNA and RNA data across all four time points. In total, 218 
differentially transcribed pathways were defined as having a mean log10(RNA/DNA) 
significantly different from zero at each later time point using a linear model. We subjected 
these nominal P values to false discovery rate correction following the Benjamini–Hochberg 
method with α = 0.05. We then explored the consistency of the differential regulation of 
each pathway by exploring the overlap at each time point.
Life Sciences Reporting Summary
Further information on experimental design is available in the Life Sciences Reporting 
Summary.
Data availability
Sequence data have been deposited in the Sequence Read Archive under BioProject ID: 
PRJNA354235. Data from the Health Professionals Follow-up Study, including metadata not 
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included in the current manuscript but collected as a part of the MLVS, can be obtained 
through written application. As per standard controlled access procedure, applications to use 
HPFS resources will be reviewed by our External Collaborators Committee for scientific 
aims, evaluation of the fit of the data for the proposed methodology and verification that the 
proposed use meets the guidelines of the Ethics and Governance Framework and the consent 
that was provided by the participants. Investigators wishing to use HFPS or MLVS cohort 
data are asked to submit a brief (two pages) description of the proposed project ('letter of 
intent') to E.B.R. (HPFS Director; erimm@hsph.harvard.edu).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Experimental design
308 participants from the MLVS, nested within the HPFS cohort, were recruited to assess 
the stability of microbiome communities, metagenomes and metatranscriptomes. 
Participants provided up to four stool samples using a previously validated self-sampling 
method21. One set of stool samples was collected 24–72 h apart followed by a second set 
approximately 6 months later. Metagenomic and metatranscriptomic reads were generated to 
provide taxonomic, functional metagenomic and transcriptional features for stability 
assessment.
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Fig. 2. Inter-individual differences in organismal composition and functional potential appear to 
be preserved, unlike the more variable metatranscriptomes
a, 1 – Jaccard Index (fraction of shared features) between all possible pairwise combinations 
of the first faecal sample with the other three samples collected from each individual (n = 
308). 95% confidence intervals are shown in grey. b, Bray–Curtis β-diversity scores within 
and between subjects for short- (24–72 h; n = 308 individuals) and intermediate-term 
intervals (6 months; n = 160 individuals). Here, species represents taxonomic profile 
abundances, DNA represents metagenomic functional profiles, and RNA represents 
metatranscriptomes. Boxplot whiskers include observations within 1.5 interquartile range of 
the upper and lower quartiles.
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Fig. 3. Stability of individual species, genes and transcripts over 6 months is correlated with 
average baseline relative abundance and prevalence
Each point represents an individual feature—species (n = 139), genes (n = 1,952) or 
transcripts (n = 1,803). Coloured circles highlight species and gene families discussed in the 
main text, according to the figure legend.
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Fig. 4. Relating metagenomic and metatranscriptomic stability over time
Genomic instability appears to explain a large proportion of transcriptomic instability over 
intermediate-term (6 month) periods (r2= 0.74); the metatranscriptome should typically be 
no more stable than the metagenome. In addition, we investigated whether dominant 
expression of stable genes versus expression of unstable genes varied according to species. 
For each transcript (n = 1,803), a dominant contributing species was identified based on the 
maximal average contribution to each transcript. We then ranked the species according to the 
total number of genes that they dominantly expressed and (for presentation purposes) 
selected those contributing to 30 or more and overlaid them on the scatterplot in colour 
(grouped by genus). Each point represents an individual feature.
Mehta et al. Page 18
Nat Microbiol. Author manuscript; available in PMC 2018 June 25.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 5. Exploring the stability of gene expression
a, For a large proportion of transcriptional pathways over- or under-expressed over time in 
the stool, this differential expression may be consistent. The Venn diagram shows 
consistency of differentially transcribed pathways (mean RNA/DNA ratios >2 across at least 
one time point; n = 218) across 4 stool samples. b, A subset (n = 8) of stably transcribed 
pathways is highlighted, according to those with the lowest coefficient of variance of mean 
RNA/DNA expression ratios across the four time points. Many of the stable pathways 
appear to be involved in cellular housekeeping, such as carbon metabolism (over-expressed; 
above dashed red line; >1) and amino acid synthesis (under-expressed; below dashed red 
line; <1). Error bars indicate 95% confidence intervals.
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Supplementary discussion 
Stool samples for this study were collected following a previously-established protocol 
involving delivery of sample material fixed in RNAlater to the laboratory. 1 Analyses from 
our pilot study demonstrated that two-day simulated shipping of RNAlater-fixed stool 
aliquots had only a minimal perturbative effect on the gut metagenome and 
metatranscriptome when compared to fresh-frozen sample collection protocols.1 Since 
publication of our pilot work, other studies have confirmed no significant effect of 
RNAlater on community composition.2,3 One study, however, has suggested differences 
in evenness in microbial taxonomic composition in stool stored in RNAlater compared to 
−80 °C controls.4 Notably, variation attributable to storage method was markedly smaller 
than the variation explained by different sample time points. Furthermore, variation 
attributed to RNAlater relative to freezing at -80℃, was comparable to that introduced by 
sample storage in OMNIGene.Gut, another popular sample stabilization kit. Taken 
together, the effect of RNAlater on microbiome sample composition is local, of very 
small effect when significant at all, and no greater than that of any other currently used 
sample stabilization method. 
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Supplementary Figure 1:  Ordination plot of taxonomic profiles (n=929).  8 outliers (samples) were 
removed.  4 of these came from one person who reported a colectomy at the time of participation in the 
study.   
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Supplementary Table 1. Reliability in measuring relative abundance levels over short-term (24-72 hours) 
and long-term (~6 months) intervals for the majority of species and gene families. Genes were most 
highly repeatable, followed by species, and then distantly followed by RNA pathways.  An ICC of <0.40 
suggests poor repeatability, 0.40 to 0.75 indicates fair to good repeatability, and > 0.75 indicates excellent 
repeatability 
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 Percent of features with an ICC > 0.40 
 Short-term Long-Term 
Species (n=146) 96.8% 86.8% 
DNA (n=1951) 99.9% 92.8% 
RNA (n=3566) 1.3% 0.79% 
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